The summit began at 8:00 AM sharp in the main hall, a vast, high-security chamber designed for classified discussions. The seating arrangement was strictly assigned based on rank and clearance level.

  At the center of the hall, a circular panel was set up for the key scientific speakers and UN-appointed advisors. Adrian Vale was seated among them, positioned directly to the right of the UNSC Chair, alongside other leading biotech innovators, high-ranking military officials, and senior WHO representatives. His presence there marked his critical role in shaping discussions on human augmentation and global biotech policy. His seat was strategically placed to allow direct engagement with world leaders, ensuring that he was both a speaker and an active participant in shaping the direction of discussions.

  Further down the tiered seating, government delegates, defense officials, and intelligence representatives were seated by region and affiliation. At the periphery, select corporate leaders from biotech conglomerates had limited access.

  Mira, assigned as part of the scientific documentation team, was seated in the second row behind Adrian’s section, among research analysts and security-cleared scientific correspondents. She used her registered laptop to take meeting minutes—an approved device that had undergone multiple security checks.

  However, as per protocol, all notes were stored in a controlled system and could not be transferred externally. She would later receive the official recorded transcripts from the summit organizers, ensuring accuracy and classified integrity.

  Mira seamlessly coordinated between Adrian and the event organizers to ensure every aspect of the meeting ran smoothly. She arrived ahead of time, checking in with the administrative team to confirm seating arrangements, access levels, and the designated note-takers for the official meeting minutes.

  Her role was not just logistical; she acted as a crucial bridge between Adrian and the policymakers, ensuring he was informed of any last-minute adjustments in the agenda or key participants who might shift the discussion dynamics.

  Before the session began, Mira liaised with the event staff to ensure that any materials Adrian required—documents, data sheets, or reference notes—were correctly placed at his seat.

  She also verified that the authorized media personnel adhere to their access restrictions, ensuring that only pre-approved reporters are present and that no unauthorized recordings are made.

  The schedule of the summit day was relentless, structured down to the minute to ensure that every discussion, every presentation, and every negotiation happened with precision.

  The summit’s intention was not merely to showcase scientific advancements but to confront the complex geopolitical and ethical challenges at the intersection of biotechnology, environmental stress, and human adaptation. Topics ranged from the cognitive toll of climate anxiety and air pollution, to ageing in high-stress urban environments, to the rising wave of human enhancement research being explored as a response to societal collapse.

  Every discussion was a careful negotiation—between innovation and precaution, between public good and corporate ambition, between the promise of longevity and the cost of altering what it means to be human.

  Adrian’s role was crucial, as a designated scientific narrator—an expert invited to guide the summit through the deeper implications of the emerging data. His insights framed the sessions, connecting clinical trials, population studies, and neurological modelling into a shared foundation of understanding.

  At the center of those debates stood Project Helix—a controversial yet increasingly celebrated initiative designed to accelerate neural adaptability through RNA-based modulation. Positioned by its supporters as a potential solution to the psychological strain caused by environmental degradation, urban overstimulation, and aging populations, Helix had become the summit’s most anticipated—and polarizing—topic.

  Governments viewed it as a strategic tool: a way to maintain workforce resilience under growing climate pressure, extend cognitive longevity, and prepare for the mental toll of population displacement. Industry leaders saw a frontier of untapped biomedical profit. Defence representatives whispered about adaptive emotional control in high-stress operations.

  In closed circles, Helix was already being called the evolution shortcut.

  Then came the voice that broke into open discussion.

  “With all due respect,” began Minister Cordain of the European Health Directorate, adjusting his glasses as his image flickered across the central conference stream, “we are past the point of speculation. We are facing population contraction. Birth rates are plummeting, retirement age is climbing, and our cognitive care infrastructure is unsustainable. If Project Helix can help preserve memory, focus, and executive function well into the eighth or ninth decade of life, then we are not discussing enhancement. We are discussing survival.”

  Several delegates nodded.

  Before Adrian could respond, another voice joined in—Dr. Lin Yukari, clinical neuropsychiatrist and lead advisor to the East Asia Cognitive Health Initiative.

  “And it’s not just about aging. We’re seeing sharp increases in neuroadaptive disorders, stress-induced dissociation, and trauma-linked cognitive decline. The brain is collapsing under the weight of our own systems—pollution, overstimulation, overwork. Helix isn’t unnatural. It’s an overdue correction.”

  “With proper sequencing,” Dr. Lin continued, “we’re not just preserving memory. We’re recalibrating harmful cognitive loops—chronic anxiety, irrational fear responses, trauma-induced executive dysfunction. If Helix’s miRNA constructs continue to stabilize, we could downregulate overactive stress circuits and enhance neuroplasticity at a scale we’ve never seen.”

  She tapped her digital tablet, highlighting a chart behind her showing escalating global mental health statistics.

  “You all see the numbers. More and more people are showing signs of trauma—what we call PTSD, or post-traumatic stress disorder—even if they’ve never been through war. Burnout is everywhere. Even children are showing signs of severe anxiety before they turn thirteen. We’ve built a world that overwhelms the human mind.”

  A beat passed.

  “Helix offers adaptability. It can soften the signal before the system breaks.”

  Adrian waited until the room settled—until the last slide dimmed and the hum of agreement softened into expectation.

  “There is no denying that Helix presents extraordinary potential. But potential is not the same as preparedness. And preparedness is not the same as safety.”

  “What we are discussing is the modulation of emotional processing—fear, stress, grief—through targeted miRNA intervention. These are not simple reactions. They are core elements of human cognition. Altering them at the molecular level may relieve suffering, yes—but it also redefines how a person perceives the world.”

  He let that sit before continuing.

  “Trials conducted on individuals with trauma, anxiety, or stress—no matter how voluntary—raise profound ethical concerns. Consent given in a vulnerable state cannot be assumed to be neutral. And even if clear consent is established, the neurological impact of this kind of adjustment is irreversible.”

  No one interrupted.

  “Previous study tried it in cancer, a miRNA mimic meant to quell oncogenes—but the body turned on them. Four people died. A single mis-sequenced strand, not rewriting DNA, but blowing circuits with immune fury. And now—we plan to do it in minds?”

  This story has been stolen from Royal Road. If you read it on Amazon, please report it

  He looked toward the side of the room, not dramatically, but deliberately.

  “If the issue is our environment—our systems, our cities, our way of life—then changing the brain to tolerate it should not be the first step. Especially not on populations already under psychological strain. We need to decide whether we are building solutions for the world—or asking the mind to endure its failures.”

  There was a pause.

  Then came the voice of Minister Youssef, representing a major Middle Eastern economic bloc. His tone was polished, tempered with authority.

  “We understand the risks, Dr. Vale. And we respect your caution. But we must also weigh those risks against what we stand to gain.”

  He folded his hands neatly on the table.

  “History has shown us that every leap forward—vaccines, organ transplants, gene therapy—was built on difficult decisions. No advancement comes without trial. Without discomfort. We regulate, we refine, we proceed. That is the nature of progress.”

  His gaze moved across the panel.

  “Our populations are ageing. Mental health disorders are surging. Our systems cannot bear the weight. If Helix offers even a partial solution, it would be irresponsible not to explore it—thoroughly, and urgently.”

  “The question isn’t whether there is risk. The question is whether we are willing to accept short-term limitations in order to secure long-term stability.”

  He turned slightly in his chair, angled just enough to signal respect without concession.

  “We cannot afford to let caution become paralysis.”

  A biotech executive from the North American delegation leaned forward, voice smooth with practiced certainty.

  “The minister is right. Risk is part of the process. With proper oversight, Helix could reshape how we handle everything from trauma recovery to workforce sustainability. The science is ready. What we need now is resolve.”

  Another followed—Dr. Suda, a senior health policy advisor from Southeast Asia.

  “In high-density nations, the crisis isn’t abstract. It’s daily. Urban trauma, collapse from burnout, suicide in adolescence—these are not theoretical threats. Helix isn’t a luxury. It’s protection. The longer we wait, the more lives we quietly lose.”

  The debate had reached a sharp edge.

  Then—

  A hand rose.

  Small. From the second row, directly behind the central table. Not a delegate. Not even on the mic list.

  The chairman noticed it before anyone else. His gaze paused on the badge clipped to her lapel. He turned slightly in his seat, studying her face with a faint narrowing of his eyes—not dismissive. Measuring.

  A few others followed his glance, realizing it wasn’t a dignitary raising their hand—but an assistant.

  “Miss Larkspur, correct? You have a comment?”

  “If I may ask.” Mira lowered her hand slowly. Her voice stayed level.

  "Is this how we have chosen to resolve all our issues now?"

  Her voice cut into the conversation like clean water through dust.

  Several heads turned. One delegate’s tablet froze mid-scroll.

  “We’ve spent decades building systems that wear people down—economies that depend on overwork, cities that push people into isolation, and jobs that reward exhaustion. And now that people are breaking… we say the answer is to rewire them.”

  Mira sat as she was, her words sharpened by something deeper than anger: clarity.

  “Governments are supposed to build environments where people can live well—not just survive. Companies are supposed to create conditions that support mental health, not just productivity. And when those systems fail, the solution isn’t to change how people feel about it. It’s to change the system.”

  She let the weight of that land before continuing.

  “But now, we’re offered something faster. If someone feels fear, we can mute it. If someone’s too sad to keep going, we can override it. If they’re exhausted by constant stress, we can make their minds more adaptable.”

  A pause.

  “And maybe, for some, that sounds like healing. But if we make it easy—commonplace—to alter someone’s memory, their instinct, their emotional core… that’s not a cure. That’s changing who they are.”

  And now her voice lowered—but somehow, it carried further.

  “If the same technology can be used to dull empathy… to remove hesitation… to suppress fear in soldiers—then what happens next? You don’t end war. You escalate it. You don’t stop pain. You make it easier to send someone straight into the fire without ever questioning what they’ve become.”

  She looked up toward the panel.

  “Is that really what Helix is meant to be?”

  She said no more.

  But the room… changed.

  For the first time, someone had asked the right question—the kind that left no room for deflection.

  Across the table, one of the research coordinators turned toward her, just slightly, as if recalibrating some internal measure.

  Among the assistants, there was a new stillness, a pause in the usual rustle of notes. A delegate’s hand hovered over their tablet, then tapped a single, deliberate line. The head of the regional policy group, three rows ahead, did not turn—but his attention, for the barest moment, did.

  By the end of the discussions, no definitive agreements were reached—such matters took time—but the framework for global biotech governance had been set into motion. As attendees gathered their documents and prepared to leave, there was an undeniable sense that history was unfolding in real time.

  ?

  The heavy doors of the conference hall eased shut, sealing away the remnants of intense debate. The atmosphere inside had been uncompromising—policy officials, scientists, and security analysts locked in high-stakes discussions on the governance of cutting-edge biotechnology. Now, as the session concluded, the weight of unresolved questions hung in the air, but for the moment, there was a pause.

  Adrian stepped out into the private lounge reserved for key participants. The room was a stark contrast to the formal intensity of the meeting hall—softer lighting, deep leather chairs, and discreetly stationed attendants offering refreshments. The large windows framed the city skyline, bathed in the warm glow of the setting sun.

  Mira was already there, speaking in hushed tones with the event’s coordinators. She had spent the session at the periphery, ensuring every exchange was documented, liaising with the organizers to streamline records, and fielding quiet but urgent messages from stakeholders who wanted follow-ups with Adrian. Now, she glanced up from her tablet, meeting Adrian’s gaze as he entered.

  “You held them together well,” she remarked, handing him a glass of water. “Security wants a separate briefing on restricted tech protocols. I’ve slotted that for tomorrow. But for now, you have a break.”

  Adrian accepted the glass, fingers tapping it once as he sat down—expression still composed, but his eyes sharper than usual, as if the earlier debate hadn’t quite left his mind. “That wasn’t part of your job description.” He spoke with a smirk.

  “Exactly why I took this position. Comes with better side quests.” She answered unbotheringly and then turned to him, already halfway out of her composed assistant mode.

  “Are they actually going through with that project? And those people seriously think it’s helpful to change how someone’s mind works?”

  Her hands were mid-air before she even realized she was gesturing. Adrian leaned back, resting the glass lightly against his knee, the faintest suggestion of a grin pulling at one corner of his mouth.

  “Were you about to go on an all-out war with them up there?”

  She huffed. “I was professional. Totally calm.”

  She spun back toward her tablet, muttering—more to the ceiling than to him.

  “They have no heart. None. They don’t fix the world, then throw Helix at the symptoms like it’s a cure-all. What now—ask my grandmother to rejoin the workforce at ninety because her brain’s been chemically upgraded?”

  Adrian exhaled through his nose, the kind of sound that was almost a laugh.

  “You do realize that wasn’t in the policy brief?”

  “No,” she snapped. “But it’s exactly the kind of thing that would be.”

  He watched her, the weight of the summit still pressing behind his eyes, behind his shoulders. The room hadn’t softened—conversations still moved around them, assistants passing notes, delegates exchanging careful words—but Mira stood out like she always did. She was completely serious. Fierce, unshaken. Still speaking from the same fire that had pushed her to stand and question them all.

  And somehow, despite everything—the tension, the stakes, the exhaustion—it made him want to laugh. At the fact that she’d just told off half the summit and was now arguing with him like this was any ordinary Thursday.

  Nearby, a few people glanced over. Just for a second. Her voice wasn’t loud, but the honesty in it was hard to ignore. And Adrian, for the first time since the session ended, felt the tight edge in his chest ease—because Mira Larkspur didn’t care who was in the room. She would still speak the truth exactly as she saw it.

  He let the moment settle, then straightened slightly, returning to the rhythm of things.

  “We’ll need to debrief before the cruise,” Adrian noted. “An hour should be enough.”

  Mira tapped her screen once to mark the shift, already switching into her next task. “Everything’s set for the transition. The organizers will begin escorting guests to the docks soon. We can go with the first group or wait for the later transfer.”

  He gave a short breath, then refocused. “Let’s get through the key points now. After that, we’ll head to the cruise.”

  Without missing a beat, Mira adjusted her earpiece and stepped aside, forwarding the final confirmations. The pause wouldn’t last long. The next stage was already on its way.

  ?